Search research articles
Contact Us
Filters
Showing results (81-90 of 485) with videos related to
Page
of 49
Sort By:
BMC Nephrology
|
January 17, 2014
Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
Yunyu Huang, Qiyun Zhou, Flora M Haaijer-Ruskamp, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 7, 2017
Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand
Onwipa Rochanathimoke, Arthorn Riewpaiboon, Maarten J Postma, et al.
Clinical Therapeutics
|
November 19, 2013
Cost-effectiveness of everolimus for second-line treatment of metastatic renal cell carcinoma in Serbia
Jovan Mihajlović, Petros Pechlivanoglou, Ana Sabo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 16, 2017
An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands
Simon van der Pol, Fabian Degener, Maarten J Postma, et al.
Vaccine
|
April 17, 2024
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations
Simon van der Pol, Florian Zeevat, Maarten J Postma, et al.
Plos One
|
January 5, 2024
The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women
Didik Setiawan, Nunuk Aries Nurulita, Sudewi Mukaromah Khoirunnisa, et al.
Health Economics
|
February 13, 2014
The effect of financial and educational incentives on rational prescribing. A state-space approach
Petros Pechlivanoglou, Jaap E Wieringa, Tim de Jager, et al.
Influenza and Other Respiratory Viruses
|
August 11, 2015
Retrospective public health impact of a quadrivalent influenza vaccine in the United States
Pascal Crépey, Pieter T de Boer, Maarten J Postma, et al.
Clinical Therapeutics
|
February 2, 2015
Reimbursement of targeted cancer therapies within 3 different European health care systems
Jovan Mihajlović, Christiaan Dolk, Keith Tolley, et al.
Journal of Multidisciplinary Healthcare
|
October 28, 2024
One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?
Yudisia Ausi, Melisa Intan Barliana, Maarten J Postma, et al.
Page
of 49
Search research articles
Search
Showing results (81-90 of 485) with videos related to
Sort By:
Page
of 49
BMC Nephrology
|
January 17, 2014
Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review
Yunyu Huang, Qiyun Zhou, Flora M Haaijer-Ruskamp, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 7, 2017
Health related quality of life impact from rotavirus diarrhea on children and their family caregivers in Thailand
Onwipa Rochanathimoke, Arthorn Riewpaiboon, Maarten J Postma, et al.
Clinical Therapeutics
|
November 19, 2013
Cost-effectiveness of everolimus for second-line treatment of metastatic renal cell carcinoma in Serbia
Jovan Mihajlović, Petros Pechlivanoglou, Ana Sabo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 16, 2017
An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands
Simon van der Pol, Fabian Degener, Maarten J Postma, et al.
Vaccine
|
April 17, 2024
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations
Simon van der Pol, Florian Zeevat, Maarten J Postma, et al.
Plos One
|
January 5, 2024
The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women
Didik Setiawan, Nunuk Aries Nurulita, Sudewi Mukaromah Khoirunnisa, et al.
Health Economics
|
February 13, 2014
The effect of financial and educational incentives on rational prescribing. A state-space approach
Petros Pechlivanoglou, Jaap E Wieringa, Tim de Jager, et al.
Influenza and Other Respiratory Viruses
|
August 11, 2015
Retrospective public health impact of a quadrivalent influenza vaccine in the United States
Pascal Crépey, Pieter T de Boer, Maarten J Postma, et al.
Clinical Therapeutics
|
February 2, 2015
Reimbursement of targeted cancer therapies within 3 different European health care systems
Jovan Mihajlović, Christiaan Dolk, Keith Tolley, et al.
Journal of Multidisciplinary Healthcare
|
October 28, 2024
One Step Ahead in Realizing Pharmacogenetics in Low- and Middle-Income Countries: What Should We Do?
Yudisia Ausi, Melisa Intan Barliana, Maarten J Postma, et al.
Page
of 49